• Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Our Capability
  • Partnership
  • Products
  • DHP Healthcare
  • Ethics and ESG
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

About Us

Wyntra is a pharmaceutical company commercializing complex and differentiated prescription medicines


Our core markets are the United States of America and the United Kingdom


The leadership team have deep sector in-market and international experience across specialty and generic pharmaceuticals


Our Values

We innovate

We do what is right

We innovate

Novel products and solutions,
new ways of working

We care

We do what is right

We innovate

 For our patients, employees, stakeholders and our world 

We do what is right

We do what is right

We do what is right

Open, honest, respectful

in everything we do

Environmental

Environmental

Environmental

Partners who use renewable energy sources


Sustainable packaging 


Digital supply chain control tower  

Social

Environmental

Environmental

Workplace equality

Community and charity partners 


Hybrid working practices


Mental health support  

Governance

Environmental

Governance

Ethical business


Diversity 


Accurate reporting

Wealth of Experience

 The Leadership Team’s international experience spans a wide range of specialty and generics organisations 

Leadership Team

Terry Coughlin

Rahul Dhorajiwala

Terry Coughlin

Chief Executive Officer

  

As Chief Executive Officer, Terry Coughlin oversees the entire Wyntra business with a special focus on US commercialization.


A seasoned life sciences leader with over 30 years in global pharmaceuticals and young start-up organisations, Terry has significant experience of corporate transformation and growth, and a deep knowledge of the finished dosage and active ingredient markets in both the US and India. 


Terry served as CEO at Strides Pharma USA and Glenmark, and as COO at Endo International, in addition to previous roles at Dr Reddy’s and Wyckoff Chemical. His management experience spans sales, marketing, manufacturing and operations in multiple locations across the US and India.

Terry holds a BS degree in chemistry from Central Michigan University.

Rahul Garella

Rahul Dhorajiwala

Terry Coughlin

Chief Commercial Officer

  

As Chief Commercial Officer, Rahul Garella manages the global commercial function at Wyntra.


With over 27 years of international experience in specialty and generic pharmaceuticals, Rahul has a deep understanding of the drivers of commercial and operational growth and profitability.


Rahul was the CCO for international markets at Strides Pharma, and EVP for international markets at Endo Pharmaceuticals. Previously Rahul held senior positions at PAR Pharmaceutical and Glenmark.


Rahul holds a BEng degree in engineering from the JMI University of New Delhi and an MBA from IMT Ghaziabad.

Rahul Dhorajiwala

Rahul Dhorajiwala

Rahul Dhorajiwala

Chief Operations Officer

  

As Chief Operations Officer, Rahul Dhorajiwala is in charge of global operations at Wyntra.


Rahul is a pharmaceutical scientist with more than 25 years' experience in drug development and launch. 


Rahul was director of global Launches at Advanz, delivering more than 100 licensing and development projects. Previously, Rahul held management roles at Glenmark, IVAX and GSK. His primary expertise lies in project management and business development, with deep experience also in formulation, quality, supply chain, and regulatory affairs.


Rahul holds a BSc degree in Pharmaceutical Science from De Montfort University and an MSc in Pharmaceutical Technology from King’s College, London.

Product Strategy

Generics

Generics

Generics

Niche

Complex

Retail and Hospital

Brands

Generics

Generics

Specialty

+Device (PFS, Bags)

Branded products

Differentiated

Differentiated

Differentiated

Repurposing

Line Extensions

PoM to P/Rx to OTC

Turnaround

Differentiated

Differentiated

Distressed Assets

Non-strategic assets

Commercial focus 

Timeline

  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy

Wyntra Holdings Limited

Copyright © 2023 Wyntra - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept